Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inequality and the marginal well-being costs of lockdowns: the case of Chile's local lockdowns design.

International journal for equity in health·2026
Same author

Analyzing digital societal interactions and sentiment classification in Twitter (X) during critical events in Chile.

Heliyon·2024
Same author

Assessing the impact of small firm dynamics on public mental health amid the pandemic in Latin America.

BMC public health·2024
Same author

Study of the Antibacterial Capacity of a Biomaterial of Zeolites Saturated with Copper Ions (Cu<sup>2+</sup>) and Supported with Copper Oxide (CuO) Nanoparticles.

Nanomaterials (Basel, Switzerland)·2023
Same author

Computational Study of the Influence of α/β-Phase Ratio and Porosity on the Elastic Modulus of Ti-Based Alloy Foams.

Materials (Basel, Switzerland)·2023
Same author

Facial biotype classification for orthodontic treatment planning using an alternative learning algorithm for tree augmented Naive Bayes.

BMC medical informatics and decision making·2022

Related Experiment Video

Updated: Jun 30, 2026

Basics of Multivariate Analysis in Neuroimaging Data
06:35

Basics of Multivariate Analysis in Neuroimaging Data

Published on: July 24, 2010

16.8K

Multimodal Alzheimer's disease classification through ensemble deep random vector functional link neural network.

Pablo A Henríquez1, Nicolás Araya2,3

  • 1Departamento de Administración, Universidad Diego Portales, Santiago, Chile.

Peerj. Computer Science
|February 3, 2025
PubMed
Summary

This study enhances early Alzheimer's disease (AD) detection using multimodal data and deep learning. Ensemble deep RVFL models achieved 98.8% accuracy, improving diagnosis for AD and mild cognitive impairment.

Keywords:
Alzheimer’s diseaseMultimodal machine learningRandom Vector functional link neural networks

More Related Videos

Author Spotlight: Advancing Alzheimer's Research &#8211; Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

942
Author Spotlight: Advancing Large-Scale Neural Dynamics Through HD-MEA Technology
09:44

Author Spotlight: Advancing Large-Scale Neural Dynamics Through HD-MEA Technology

Published on: March 8, 2024

4.6K

Related Experiment Videos

Last Updated: Jun 30, 2026

Basics of Multivariate Analysis in Neuroimaging Data
06:35

Basics of Multivariate Analysis in Neuroimaging Data

Published on: July 24, 2010

16.8K
Author Spotlight: Advancing Alzheimer's Research &#8211; Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

942
Author Spotlight: Advancing Large-Scale Neural Dynamics Through HD-MEA Technology
09:44

Author Spotlight: Advancing Large-Scale Neural Dynamics Through HD-MEA Technology

Published on: March 8, 2024

4.6K

Area of Science:

  • Neuroscience
  • Artificial Intelligence
  • Medical Diagnostics

Background:

  • Alzheimer's disease (AD) pathogenesis is complex, involving neuronal loss and characteristic brain pathologies.
  • Early AD detection is crucial for intervention but challenged by data variability and single-modality research.
  • Current methods often struggle with comprehensive staging due to incomplete or inconsistent data.

Purpose of the Study:

  • To improve early detection and staging of Alzheimer's disease (AD) and mild cognitive impairment (MCI).
  • To address limitations of single-modality data by integrating multimodal information (clinical, genetic).
  • To evaluate the efficacy of deep learning models, specifically random vector functional link (RVFL) networks, for AD diagnosis.

Main Methods:

  • Integration of multimodal data, including clinical and genetic information.
  • Application of deep learning (DL) models, with a focus on ensemble deep RVFL (edRVFL) networks.
  • Utilization of advanced data imputation techniques, such as Winsorized-mean (Wmean), to handle data incompleteness.

Main Results:

  • The edRVFL model demonstrated superior performance in detecting early AD stages.
  • Achieved high diagnostic metrics: 98.8% accuracy, 98.3% precision, 98.4% recall, and 98.2% F1-score.
  • Outperformed traditional machine learning models (SVM, Random Forests, Decision Trees) in AD detection.

Conclusions:

  • Integrating multimodal data with advanced DL techniques significantly enhances early AD detection.
  • Ensemble deep RVFL models, coupled with effective imputation, offer a powerful approach for AD and MCI diagnosis.
  • This study highlights the potential of sophisticated computational methods for improving neurological disorder diagnostics.